Production of Eicosapentaenoic Acid and Fucoxanthin in Cold-Tolerant Diatom Strains
Diatoms hold great potential for nutraceutical production as they are source of high value products such as eicosapentaenoic acid (EPA) and pigment fucoxanthin. EPA has proven human health benefits, and fucoxanthin can be used as both medicinal and nutritional ingredient to prevent and treat chronic diseases. The economic perspective of commercial production of a single product from microalgae is not attractive due to the high production cost. To improve the economic viability, we explore the concept of combining the production of both EPA and fucoxanthin in a single process. In our current study, we isolated twelve new microalgae isolates from Ofotfjord. Eight of them are diatoms and 4 of them are cyanobacteria and microalgae. Screening the new diatom isolates revealed that two strains are cold-tolerant diatom which can grow at 10 °C. They accumulated significant amount of lipid, which was up to 40-60% of the dried mass. The EPA contents from the two strains ranged from 15-19% of the total fatty acid, while fucoxanthin concentrations were between 1-1.4% of the dried biomass. Comparing with other studied diatom, this is promising result. The two strains hold promise as source for EPA and fucoxanthin production.Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 360
 J. Dyerberg, “Linolenate-derived Polyunsaturated Fatty Acids and Prevention of Atherosclerosis”. Nutr. Rev. 44, 1986, pp.125–134.
 S. Nomura, S. Kanazawa, S. Fukuhara, “Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus”. J. Diabetes Complicat. 17, 2003, pp.153–159.
 M. Asgharpour, B. Rodgers, J.A. Hestekin, “Eicosapentaenoic acid from Porphyridium cruentum”: Increasing growth and productivity of microalgae for pharmaceutical products. Energies 8, 2015, pp.10487–10503.
 F.E. González, R.V. Báez. “In time: Importance of omega 3 in children’s nutrition”. Rev Paul Pediatr 35(1), 2017, pp. 3-4.
 J.M. Lee, H. Lee, S. Kang, W.J. Park. “Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological” Advances Nutrients 8(1), 2016, 23.
 B.B. Guo, B. Liu, B. Yang, P.P. Sun, X. Lu, J. Liu, F. Chen, “Screening of diatom strains and characterization of Cyclotella cryptica as a potential fucoxanthin producer”. Mar Drugs 14, 2016, 125.
 P. Kuczynska, M. Jemiola-Rzeminska, K. Strzalka. “Photosynthetic pigments in diatoms”. Mar Drugs 13, 2015, pp. 5847–5881.
 H. Maeda, M. Hosokawa, T. Sashima, K. Murakami-Funayama, K. Miyashita K “Anti-obesity and anti-diabetic effects fucoxanthin on diet-induced obesity conditions in a marine model”. Mol Med Rep 2, 2009, pp.897-902.
 T. Tanaka, M. Shnimizu, H. Moriwaki, “Cancer chemoprevention by carotenoids”. Molecules 17, 2012, pp. 3202–3242.
 H. Yoshioka, M. Ishida, K. Nishi, H. Oda, H. Toyohara, T. Sugahara, “Studies on anti-allergic activity of Sargassum horneri extract”. J Funct Foods 10, 2014, pp.154-160.
 H. Zhang, Y. Tang, Y. Zhang, S. Zhang, J. Qu, X. Wang, R. Kong, C. Han, Z. Liu, “Fucoxanthin: A Promising Medicinal and Nutritional Ingredient”. Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 723515, 10 pages.
 M. Petrushkina, E. Gusev, B. Sorokin, N. Zotko, A. Mamaeva, A. Filimonova, M. Kulikovskiy, Y. Maltsev, I. Yampolsky, E. Guglya, V. Vinokurov, Z. Namsaraev, D. Kuzmin, “Fucoxanthin production by heterokont microalgae”. Algal Research, Volume 24, Part A, 2017, pp. 387-393.
 S. Wang, S. K. Verma, I. Hakeem Said, et al., “Changes in the fucoxanthin production and protein profiles in Cylindrotheca closterium in response to blue light-emitting diode light”. Microb Cell Fact 17, 2018, 110.
 X. Xiao, X. Si, Z. Yuan, X. Xu, G. Li, “Isolation of fucoxanthin from edible brown algae by microwave-assisted extraction coupled with high-speed countercurrent chromatography”. J Sep Sci 35, 2012, pp.2313–2317.
 S. Xia S, K. Wang, L. L. Wan, A. Li, Q. Hu, C. W. Zhang, “Production, characterization, and antioxidant activity of fucoxanthin from the marine diatom Odontella aurita”. Mar Drugs 11, 2013, pp. 2667–2681.
 R. R. L. Guillard, “Culture of phytoplankton for feeding marine invertebrates”. In Smith, W. L. and Chanley, M. H. (Eds) Culture of Marine Invertebrate Animals, Plenum Press, New York, 1975, pp. 26-60.
 S. M. Kim, S. W. Kang, O. N. Kwon, D. Chung, C. H. Pan, “Fucoxanthin as a major carotenoid in Isochrysis aff. galbana: characterization of extraction for commercial application”. J Korean Soc Appl Biol Chem 55, 2012, pp. 477–483.
 V.I. Ryabushko, S.N. Zheleznova, M.V. Nekhoroshev, “Effect of nitrogen on the accumulation of fucoxanthin from diatom Cylindrotheca closterium (Ehrenb.) Reimann et Lewin”. Algologia 27(1), 2017, pp. 15–21.
 X. Mao, S. H. Y. Chen, X. Lu, J. Yu, B. Liu, “High silicate concentration facilitates fucoxanthin and eicosapentaenoic acid (epa) production under heterotrophic condition in the marine diatom Nitzschia Laevis”. Algal research, 52, 2020, 102086.
 T. K. Marella, A. Tiwari, “Marine diatom Thalassiosira weissflogii based biorefinery for co-production of eicosapentaenoic acid and fucoxanthin”. Bioresource Technology, Volume 307, 2020, 123245
 R. Bhattacharjya, T. K. Marella, A. Tiwari, A. Saxena, P. K. Singh, B. Mishra. “Bioprospecting of marine diatoms Thalassiosira, Skeletonema and Chaetoceros for lipids and other value-added products”. Bioresource Technology 318, 2020, 124073.